Thursday, 16 July 2020

3D cell culture Market 2020 Industry Size, Opportunities, Analysis and Forecast To 2026

The Global 3D Cell Culture Market Size is anticipated to reach over USD 2,768.8 Million by 2026 according to a new research published by Polaris Market Research.

3D cell culture is a cluster of biotic cells that are allowed to cultivate in artificial media in three dimensions. This type of cell culture used in tissue engineering and drug discovery, due to its property of providing prognostic data for in vivo tests and physiologically pertinent statistics. 3D cell cultures have a longer lifespan as well as more stability when compared to 2D cell culture system. This property makes them appropriate for long-term studies and long-term effects of the drug on cells. 3D cell culture systems are mostly grown in 3D cell colonies or bioreactors. Research studies estimated that they function similar to natural cells. due to which they have applications in oncology research.


Some major key players in global 3D Cell Culture Market include 3D Biotek, Advanced Biomatrix, Becton, and Dickinson Company (BD), corning Incorporated, Global cell solutions Inc., Thermo Fisher scientific Inc., VWR Corporation, Nanofiber solutions, Lonza Group Ltd., Synthecon incorporated, and Tecan Trading AG among others.

Rising occurrence of several types of cancer cases and the need for effective and affordable treatment are the major factor driving the growth of the 3D cell culture market. According to the World Health Organization (WHO) 2015, it is estimated approximately 8.8 million deaths due to cancer globally. In addition, development of optimized 3D assays, growing investment in healthcare, rising R&D investments, and other research associated activities are also propelling the growth of 3D cell culture market significantly. The 3D cell cultures are majorly used for testing efficacy of new drug development, which can be further used for the treatment of chronic diseases such as cancer, cardiovascular and neurological ailments. This surges implementation of the 3D cell culture by biotechnology and pharmaceutical industries, which in turn is driving the growth of 3D cell culture market.
  

The global 3D Cell Culture Market is segmented on the basis of products type, applications, end users, and geography. On the basis of product type, the global 3D cell culture market is segmented into Scaffold-based platforms, Bioreactors, Gels, Microchips, and Services. The scaffold based platforms are further categorized into Macro-Porous scaffolds, Microporous scaffolds, Nanoporous scaffolds, Scaffold free platforms, and Solid scaffolds. Scaffold-based cultures estimated to share the highest market in 2017. Availability of a substantial number of products based on the structure maintained 3D cell culture is attributive for the estimated share of this segment.

Based on the applications the global 3D cell culture market is segmented into Drug Discovery, Stem cell research, Cancer research, and Regenerative medicine. In 2017, Application in cancer research estimated to form the largest demand for 3D cell cultures market. On the basis of end users, the global 3D cell culture market IS segmented into Academic Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Laboratories. Biotechnology & pharmaceutical sectors dominated the market in 2017, as a significance of the developed application of technology in the drug discovery procedures in order to carry out well-organized screening and board validation.
on No comments:
Labels: , , , ,

Facial Injectable Market Strategic Industry Evolutionary Analysis Till 2026 | Including COVID-19 Pandemic Business Impact

The Global Facial Injectable Market is anticipated to reach over USD 18,819.04 Million by 2026 according to a new research published by Polaris Market Research. Facial injectable products also called as dermal fillers are products that benefit in facial transformation. These facial injectable products are widely used to indulgence the early signs of age as well as wrinkles thereby increasing the visual attractiveness.

Factors such as the rise in demand to augment the visual look and growing popularity for negligibly intrusive procedures majorly drive the market. In addition, the rise in elderly population and introduction of improved facial injectable such as synthetic calcium hydroxyl apatite fillers further anticipated boosting the market growth. In recent time, growing demand for non-surgical processes for facial transformation and modification is gaining global admiration. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS), 2017, non-surgical and surgical cosmetic techniques showed an overall rise of 9% from past years. Moreover, according to the same report in 2016, nonsurgical procedures including injectable accounted for approximately 8 million globally. The global Facial Injectable Market is segmented on the basis of products, end users, and geography.


Some major key players in global Facial Injectable Market include Advanced Dermatology, Merz, Inc., Galderma Laboratories, L.P., ColBar LifeScience Ltd., Allergan, Plc., Valeant Pharmaceuticals North America LLC., Sanofi Biosurgery Inc. (Sanofi), Anika Therapeutics, Inc., Suneva Medical, Inc.among others.

On the basis of products, the Global Facial Injectable Market is segmented into Dermal Fillers/Injectable Implants and Anti-aging/ Anti-wrinkle Injections. The Dermal Fillers/Injectable Implants is further segmented into Hyaluronic Acid, Collagen Fillers, and Synthetic Fillers such as Calcium hydroxylapatite and polymethyl methacrylate microspheres. The Anti-aging/ Anti-wrinkle Injections is further categorized into Botulinum toxin A and Poly-L-lactic acid (PLLA) micro particles. On the basis of products, the hyaluronic acid segment is estimated to dominate the market in 2017. Moreover, this segment is anticipated to show lucrative growth during the forecast period. Cumulative use of hyaluronic acid as a dermal filler in the cosmetic procedure is anticipated to support the market growth. Hyaluronic acid has become an important part of cosmetics and aesthetic surgeries due to its robust water retaining properties. In general, the cosmetic-grade hyaluronic acid has the lower molecular weight which further aids to retain water in the cells, releases antioxidants, form the deep penetration of the product in the epidermis, and delays the aging progression. On the basis of the end user, the global Facial Injectable Market is segmented into Hospitals, Dermatology Clinics, Beauty Clinics, and Dermatology Research Institutes. In 2017, hospital segment is estimated to dominate the global market.



Key players are adopting partnerships and product introduction strategies in order to fulfill the unmet aesthetic as well as clinical needs thus, providing surgeons with better and novel options further augmenting the growth of the facial injectable market. For instance, in 2017, the company Galderma collaborated with Colorescience to expand its skincare solutions for persons that can be used in combination with orthodox facial injectable aesthetic treatments.


About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world


on No comments:
Labels: , , ,

Pruritus Therapeutics Market Strategic Industry Evolutionary Analysis Till 2026 | Including COVID-19 Pandemic Business Impact

The global pruritus therapeutics market is anticipated to reach over USD 17,275.12 Million by 2026, according to a new research published by Polaris Market Research, Pruritus, also known as itch disorder can be triggered by several ailments ranging from dermatological disorders such as mycoses, atopic dermatitis, chickenpox, and contact dermatitis, Pruritus is interrelated with the dermatologic and systemic causes. A typical itching generally forms the diagnosis of a key dermatologic syndrome. Several skin diseases that are related to pruritus include renal pruritus, hematologic pruritus, cholestatic pruritus, idiopathic generalized pruritus, pruritus related to malignancy and endocrine pruritus. Renal pruritus can befall in people with chronic renal failure. Increased levels of ions such as calcium, phosphate, and magnesium are found in the skin of pruritic patients.  Severe pruritus leads to scratching that causes secondary skin problems such as eczematization, dryness, infection, excoriation, Contact allergy, and lichenification.

Some major key players in global Pruritus Therapeutics Market include pruritus therapeutics market includes Allergan Inc., Amgen Inc., Astellas Pharma Inc., CARA Therapeutics, Novartis AG, and Teva Pharmaceutical Industries Ltd. among others.


The rising incidence of dermatological disorder influencing the occurrence of pruritus and subsequently, the rising demand for proper diagnostics as well as therapeutics to treat the such medical condition is anticipated to bolster the market growth. The rise in inorganic development strategies is recognized as one of the key factor boosting the growth of the pruritus therapeutic market. In addition, the key players of the pruritus therapeutic market are progressively adapting the growth strategies such as partnerships, regional acquirements, and mergers and acquisitions. Such growth strategies are anticipated to result in technological advancement owing to enhancement in the product portfolio and mutual collaboration in R&D further boosting the market growth.
  
The global pruritus therapeutics market is segmented on the basis of product, disease type, and geography. On the basis of product, the global pruritus therapeutics market is segmented into Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, and Others. In 2017, the corticosteroids are expected to dominate the market by product segment as corticosteroids are widely used as the first line of treatment. On the basis of disease type, the global pruritus therapeutics market is segmented into Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, and Others. In 2017, Allergic contact dermatitis is estimated to dominate the market segment. It is the 3rd most general cause for patients seeking consultation with a dermatology specialist. Allergic contact dermatitis is commonly observed in women.


On the basis of region, the global pruritus therapeutics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was estimated to dominate the global pruritus therapeutics market. The dominance is majorly due to The presence of favorable government initiatives and the introduction of new products. Moreover, rising incidence of target disorders and the existence of pruritus inducing climatic disorders in this region are anticipated to boost the market growth during the forecast period. However, Asia Pacific is anticipated to dominate pruritus therapeutics market. Growing incidence of atopic dermatitis and urticarial and presence of unmet healthcare organization needs are the factors attributed to the growth of the market in Asia Pacific.

on No comments:
Labels: , , , , ,

Polypropylene Market PESTEL Analysis, SWOT Study and Competitive Landscape Forecast 2026

The New report “Polyolefins Market Share, Size, Trends, Industry Analysis Report By Feedstock (Polyethylene, Polypropylene, Ethylene Vinyl Acetate, Thermoplastic Olefins, Others), By Application (Film & Sheet, Injection Molding, Blow Molding, Extrusion Coating, Fiber, Others), By Regions, Segments & Forecast, 2019 – 2026” provides a complete analysis of present market trends and future insights.

The global polyolefins market size is estimated to reach USD 447.0 billion by 2026, growing at a CAGR 6.2% during forecast period. according to a new report by Polaris Market Research. Polyolefins are the polymeric compounds of olefins and account for over 50% in weight of the produced polymers. The global market comprises more than 300 grades of commercial polyolefins with wide array of mechanical properties. The two major types of polyolefins include polypropylene and polyethylene. They are further subdivided into several grades for numerous end-use applications.

Increasing improvements in plastic technologies, creation of reasonably priced indoors fixtures in vehicles and strict business requirements regarding carbon emissions had been key elements using the enterprise. PE or Polyethylene is fast growing product in terms of volume. High tensile strength along with high impact resistance of the product has contributed to its demand in film and sheet and packaging sectors. PE can be heated to its M.P., cooled and heated again as in line with requirement without great degradation in strength or quality. This offers it prominence in geomembranes, plastic films and bags.


The worldwide polyolefins marketplace has witnessed rapid increase resulting from very excessive consumption of polyethylene and polypropylene for special end-uses. Plastic demand has grown significantly global and has led to increased consumption of polyethylene. Consumer goods and meals packaging are one of the prime drivers for polyolefin marketplace.


Infrastructure improvement, elevated monetary boom and rising according to capita intake have satisfactorily illustrated the increase of possibilities inside the polyethylene industry, resulting in extended consumption of polyolefins. The call for of polyethylene for consumables which includes films, packaging materials and several other items for massive industrial packages and home cause is an important growth parameter.

The growing monetary increase of numerous growing countries across the globe, with improved life and growing non-public disposable earning has helped using commodity products. Such phenomenon is anticipated to elevate the income sales for the end-use merchandise of polyethylene and polypropylene. The global polyolefins constitute of stringent regulatory rules, which is anticipated to be a purposeful restraint.



Many nations across the world are efficiently creating an after-use plastics economy to lessen the environmental effect of such compounds. Development in the after-use collection, reprocessing & storage infrastructure; radically increasing best, economics & uptake of recycling; and growth inside the monetary attractiveness of retaining substances in the device are a number of the crucial parameters undertaken by the enterprise gamers to beautify sustainability.

The hastily increasing countries with large populations such as China, India and Indonesia encompass very high future boom for the market. Asia Pacific is the most money-making as PE and PP consumption boom is related to substitution of conventional materials, population demographics and infrastructure improvement.

To customize the study according to your specific requirements please click At : https://www.polarismarketresearch.com/industry-analysis/global-polypropylene-market/speak-to-analyst

The polyolefin market is highly competitive and comprises large number of domestic and international players. Some of the key players in polyolefin market include ExxonMobil Chemical, DowDuPont, Sinopec Corporation, Total SA, Arkema SA LyondellBasell, SABIC and Chevron Philips Chemical Company.
on No comments:
Labels: , , , ,

Wednesday, 15 July 2020

Needle-Free IV Connectors Market Share, Industry Size, Opportunities, Analysis and Forecast To 2027

The global needle-free IV connectors market size is expected to reach USD 1,647.7 million by 2027 according to a new study by Polaris Market Research. Needle free IV connectors (NFC) are small needleless devices used within intra-venous (IV) catheters, administration sets, and syringes. NFC is the basic medical supply present in any healthcare facility to administer fluid, drug or medication in different vascular access systems. These needle-free systems are designed with the purpose to reduce needle stick injuries, bacterial contamination in the blood to improve patient outcome.

The complications associated with the needle based connectors such as catheter based blood stream infections and the catheter lumen occlusion are acting as the drivers for the NFC market. The set of NFCs are coming up with superior designs and features to reduce the length of hospital stays and economic burden.


The prominent factors responsible for the growth of NFCs market the rising hospital admission rate, particularly among geriatrics, needle stick injuries among healthcare workers, and superior quality as compared to conventional systems. In 2016, the Center of Disease Control and Prevention (CDC) estimated more than 8.5 million people in the U.S have peripheral artery disease (PAD), out of which approximately 20% of the individuals were above age 60 years. The prevalence of the PAD is estimated equal among the men and women population. The primary reason behind the widespread of these diseases is less awareness among the population, especially in growing economies of the APAC region.

Market participants such as RyMed Technologies, LLC, Baxter International Inc., CareFusion Corporation, B. Braun Melsungen AG, Nexus Medical LLC, Becton, Dickinson and Company, ICU Medical, Inc., and Vygon S.A. are some of the key players operating in the concerned market. The factors such as superior designs, unique features, user friendliness with the healthcare workers, price, technology, and strong distribution in the geographical area are the competitive forces impacting the player presence in the area. The bigger companies are focusing on signing long term exclusive distribution agreement to remain dominant force in the market. In May 2019, B. Braun and Nexus Medical signed an agreement to distribute TKO-6P luer activated anti-reflux device. This will increase customer coverage with enhanced patient care for both the parties.


on No comments:
Labels: , ,

Human Microbiome Therapeutics Market Industry Size, Opportunities, Analysis and Forecast To 2027

The global human microbiome therapeutics market size is expected to reach USD 1,544.6 million by 2027 according to a new study by Polaris Market Research. Microbiome refers to the residing micro-organisms genomes in the human body, particularly in the gut. The human body comprises more than 100 trillion microbes and around 2 million microbe genomes. These microbiota plays a significant role in the body’s physiological functions and includes viruses, bacteria, and fungi. Primarily it has Bacteroidetes (gram negative) and Firmicutes, commonly Clostridium and Lactobacillus sp. (gram positive). The majority of these are strict anaerobes, with fungi and archaebacteria comprising less than 1 per cent of the total population.


The global market is driven by an increased focus on microbiome based early diagnosis of diseases, increase in the prevalence of diseases due to dysbiosis, rising collaborations, and strongly funded government backed microbiome research projects. In November 2019, the Million Microbiome of Humans Project (MMHP) was launched in collaboration with France, Denmark, China, Latvia, Sweden and other countries to co-operate in meta-genomic research. The aim is to create the largest human microbiome database from analyzing more than one million samples gathered from reproductive tract, gut, skin, and other organs in the next few years.

Market participants such as Enterome Bioscience, Biotagenics, Seres Therapeutics, Oxidien Pharmaceuticals, LLC, BoobyBiome, 4D Pharma PLC, UBiome, Carbiotix, E.I. du Pont de Nemours and Company, Finch Therapeutics, GNUbiotics Sciences, ClearB Therapeutics, GoodBelly, GoodGut, Synlogic, Second Genome, 16S Technologies, 5QBD-Biotech, Vedanta Biosciences, Holobiome, Commense, Ferring Pharmaceuticals, Evelo Biosciences, CoreBiome, Igen Biolab Group, ViThera Pharmaceuticals, DermBiont, Hyggut, Embion Technologies, Lactobio, BiomX, Exeliom Biosciences, and LNC Therapeutics are some of the key players operating in the concerned market.


Recently, in July 2020, 4D pharma plc., the UK based pharma company engaged in the development of live bio-therapeutics announced that patient enrollment for its phase II trial of its candidate oral immune-modulator MRx-4DP0004 for patients hospitalized with COVID-19 is open, and dosing to start very soon. The company is world leader in the production of live bio-therapeutics (live microbiome used to cure disease). Its products are the orally delivered single strain bacteria, which are naturally present in the human gut.

on No comments:
Labels: , , ,

Wearable Medical Devices Market Growth, Challenges, Opportunities and Emerging Trends 2020-2027

The global Wearable Medical Devices market size is expected to reach USD 85.6 billion by 2027 according to a new study by Polaris Market Research .Wearable medical devices are defined as the autonomous devices worn by the individual to provide medical or fitness monitoring and support over a period of time. They are either worn as a body accessory or being embedded in cloth or shoes. They incorporate non-invasive sensors, wireless transmission, real time data processing capabilities, and also provide medical feedback.

Recent developments in wearable medical devices include alert mechanisms, decision support systems, and real time analysis. These wearables offer point of care, and remote management for rehabilitating individuals, disabled and chronically ill.

  
The prominent factors favoring the wearable medical devices market growth include an increase in the prevalence of lifestyle-related diseases, consumer awareness towards fitness, and advancement in technology and medical innovation with ever increasing interest of consumer electronic companies. According to the study published by the International Diabetes Federation (IDF), in 2015, there were approximately 415 million diabetic people and it is expected to increase to 640 million by 2040. The high prevalence of diabetes is an important driver boosting market growth.

With a spike in infectious diseases over the past decade, the Stanford Healthcare Innovation Lab (SHIL) set up a team to study the impact of wearables to track infectious diseases. Moreover, in April 2020, Scripps Research Translational Institute (SRTI) launched DETECT, under which data from activity trackers and smart watches would be integrated into public health surveillance program for proactive disease tracking and population health programs.

Market participants such as Medtronic plc, OMRON Corp., Biotelemetry Inc., Apple, Inc., Koninklijke Philips, Dexcom Inc., Abbott Laboratories, Verily Life Sciences, GE Healthcare, Bio-Beat Technologies, Masimo Corporation, iRhythm Technologies, Inc., Preventice Solutions, Inc., CONTEC Medical Systems Co. Ltd, VitalConnect, Minttihealth, Biotricity Inc., Cyrcadia Asia Limited., Garmin Ltd, Xiaomi Technologies, ten3T healthcare, Fitbit, Inc., and Huawei Corporation are some of the key players operating in the Wearable Medical Devices market.


Players in the market are focusing on developing low cost wearable accessible to all strata of the population within the geographic footprint. In line with this, India based Muse Wearables is manufacturing a wrist based wearable tracker at a cost of INR 3,500. With this, it will continuously monitor skin temperature, blood O2 saturation levels, and heart rate to track body vital signs to diagnose COVID-19 symptoms in early stages. The device is Bluetooth enabled and could be connected via ‘Muse Health App’.


on No comments:
Labels: , , ,

CT Scanner Market Report 2020 Competitive Landscape, Trends and Opportunities

The global CT Scanner market size is expected to reach USD 8.40 billion by 2027 according to a new study by Polaris Market Research. The report “CT Scanner Market Share, Size, Trends, Industry Analysis Report, By Type (Stationary and Portable CT Scanners); By Technology (High Slice, Mid Slice, Low Slice, and Cone Beam CT); By Architecture (C-arm and O-arm CT Scanners); By Application (Oncology, Neurology, Cardiovascular, Musculoskeletal, and Other Applications), By Regions; Segment Forecast, 2020 –2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Computed tomography is an imaging devices which enables users to look inside the specimen without cutting it. It utilizes computer systems and rotating X-rays machines to produce cross sectional images. In medical, it offers images of blood vessels, bones, and soft tissues to find any ailments or bone fractures in the human body. CT scanning is non-invasive, fast, accurate, and painless procedure. In emergency situation, it provides details of internal injuries and hemorrhage, which saves many human lives.


The prominent factors favoring the market growth include improvement in the Scanner technology, miniaturization resulting in portable CT Scanner, and rising prevalence in bone-related disorders coupled with road traffic accidents. According to the statistics published by the U.S. Center for Disease and Control (CDC), around 30 million people take part in sports related activities in the U.S. alone. Of this, individuals aged 15 to 20 accounted for around 2 million injuries and more than 30,000 hospital admissions per year.

Moreover, many start-ups are employing artificial intelligence (AI) for an accurate diagnosis. According to the study published in NVIDIA, AI could significantly drop error rate in cancer diagnosis by more than 85 per cent. In line with this, Aidoc, an Israel based start up is employing AI to decipher medical scans and in 2016, the U.S. based AI medical imaging platform Behold.ai, came up with its proprietary “red dot algorithm”. This algorithm has 90 per cent accuracy and faster scanning capability.


Market participants such as CurveBeam, Hitachi Medical Corporation, Neusoft, Samsung, Canon Medical Systems, GE Healthcare, Medtronic Inc., Accuray, Koning Corporation, Xoran, Koninklijke Philips, Carestream, Planmed Oy, Siemens Healthineers, Shenzhen Anke High-Tech, and United Imaging Technologies are some of the key players operating in the concerned market.

The players in the market are competing on different parameters such as strategic partnerships and agreements, exclusive service offerings, after-sales service, providing financing options, and warranties. In cost-sensitive untapped markets, the players are penetrating through government contracts, leasing and exclusive collaborations.


on No comments:
Labels: , , , ,

Vaccine Adjuvants Market Share, Industry Size, Opportunities, Analysis and Forecast To 2027

The global Vaccine Adjuvants Market size is expected to reach USD 1,305.7 million by 2027 according to a new study by Polaris Market Research
Adjuvant is defined as a substance which in combination with vaccine invigorates antigen specific immune reactions to increase specificity and immunogenicity of marketed vaccines administered in any individual. Adjuvants augment the impact of a vaccine providing increased immunity towards any particular infectious disease. It triggers positive immune response by mimicking pathogen associated molecular pattern (PAMP), which include lipo-polysaccharide, liposomes, cell walls of bacteria, and endo-cytosed and un-methylated nucleic acids. Adjuvant imparts beneficial effects to vaccines in several ways such as increasing its potency to grasp the higher degree of immunogenicity, reducing the number of repeated vaccinations, antigen dose reduction, widening antibody responses of the individual, and inducing T-cell responses.


The global market is driven by the recent surge in infectious diseases, extensive research on vaccines, and funding from the government. European Union (EU) through EU programme Horizon 2020, has formed ENOVA, a network on vaccine adjuvants. This will bring both industry experts and stakeholders working in the areas of vaccine research and development and adjuvant research to reduce side effects and efficacy of new developing vaccines.

Market participants such as GlaxoSmithKline Plc, Novavax, Inc., Statens Serum Institut, Viscogel AB, VaxLiant LLC, Aphios Corporation, Moderna Inc., Sanofi Pasteur, Adjuvatis, Avanti Polar Lipids, Inc., MPV Technologies, CSL Limited, Vaxine Pty Ltd, SPI Pharma, CureVac AG, Sergeant Adjuvants, Agenus, Inc., OZ Biosciences, Adjuvants Unlimited Inc., and Adjuvants Euclid Canada Inc. are some of the key players operating in the concerned market.


 To speed up the process of nCOV vaccine development big players are collaborating with industry stakeholders. In February 2020, GSK and Coalition for Epidemic Preparedness Innovations (CEPI) collaborated to ease the out nCOV vaccine development with GSK’s vaccine adjuvant platform for other players in vaccine development. Similarly, in March 2020, iBio, a contract research organization (CRO) signed a definitive agreement with the Infectious Disease Research Institute (IDRI). The combination of iBio’s VLP antigen with the latter adjuvant expected to offer promising efficacy and safety characteristics.

on No comments:
Labels: , , ,

Tuesday, 14 July 2020

Digital Map Market PESTEL Analysis, SWOT Study and Competitive Landscape Forecast 2026

According to a new research published by Polaris Market Research the digital map market is anticipated to reach over USD 9,269.5 million by 2026. In 2017, the outdoor segment dominated the global market, in terms of revenue. North America is expected to be the leading contributor to the global market revenue during the forecast period.

The increasing applications of digital maps in industries such as automotive, media & entertainment, and defense have boosted the growth of the market. Use of geospatial information in applications such as infrastructure management, risk and emergency management, urban planning, resource management, and logistics has increased the demand of digital maps over the years. Additionally, the technological innovation in the market in terms of improvement of components, and mapping software further boosts the adoption of digital maps. Increasing investments by vendors in technological advancements coupled with increasing applications of digital maps would support the market growth during the forecast period. However, high investment in data collection is expected to hamper market growth during the forecast period. Growing demand from emerging economies, and increasing adoption by small and medium businesses are factors expected to provide numerous growth opportunities in the coming years.


The adoption of digital maps is rising at a significant rate worldwide. Digital maps are increasingly being used for various applications such as civil engineering & construction, government, defense & intelligence, agriculture & forestry, transportation, real estate, and others. Varied applications of Digital Maps include topographic mapping, infrastructure planning, traffic management, and others. Defense and military sectors utilize digital maps on a large basis primarily for geospatial mapping. The increasing concern for security has led the defense sector to become a prominent buyer for geospatial intelligence and mapping services all over the world. These services are used for surveillance, battlefront analysis, strategy formulation, and situation analysis on border areas.

North America generated the highest revenue in the market in 2017, and is expected to lead the global market throughout the forecast period. The increasing applications in the commercial sectors have increased demand of digital maps in the region. The increasing demand from defense, and government sectors further boosts market growth. Local players are introducing low cost digital mapping solutions with high performance to cater to the growing consumer demand. Numerous key players have adopted partnership and expansion strategies to increase their market share in digital map markets in the region. Asia-Pacific is expected to grow at the highest CAGR during the forecast period.


The different applications in digital map include mobile devices, enterprise solutions, defense, automotive, government, and others. In 2017, the automotive segment accounted for the highest market share. Digital maps are increasingly being used in self-driving cars. Other applications of digital maps in the automotive sector include advanced driver assistance systems, fleet management, and logistics control solutions.

The well-known companies profiled in the report include DigitalGlobe, Inc., Apple, Inc., Google, Inc., HERE Holding Corporation, Environmental Systems Research Institute (ESRI), Inc., Getmapping PLC., Micello, Inc., TomTom International BV, MapData Services, Intermap Technologies Corporation, AutoNavi Holdings Ltd., and Collins Bartholomew among others. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers

on No comments:
Labels: , , ,

Omega 3 Market 2020 Manufacturers, Regions, Countries, Types and Applications, Forecast to 2026

According to a new report published by Polaris Market Research the omega 3 market is anticipated to reach over USD 4,262.5 million by 2026. In 2017, the functional food and supplements segment dominated the global market, in terms of revenue. North America was the leading contributor to the global market revenue in 2017.

A significant increase in awareness regarding a healthy diet, changing lifestyles, and health benefits offered by omega 3 drive the growth of this market.  Other driving factors include growing inclination towards use of natural and organic products, and increasing use of omega 3 in functional food and pharmaceutical. Increasing demand from developing nations is expected provide numerous growth opportunities to the market players during the forecast period.


There has been a growing awareness regarding health benefits offered by omega 3 among consumers. Omega 3 assists in body functions such as muscle activity, brain development and functioning, blood clotting, digestion, fertility, and cell division and growth, which has increased its adoption. Use of EPA also helps in controlling anxiety, depression and other related health problems.

Improvement in lifestyle due to rise in income level, especially in the developing countries of Asia-Pacific fuels the demand for omega 3 market. Factors such as increase in per capita income, changes in consumer behavior, and increased awareness regarding health and nutrition are expected to accelerate the adoption of omega 3 in the coming years.

North America generated the highest revenue in the market in 2017. The increasing geriatric population in the region coupled with high disposable income drives the market growth. The increasing demand of omega 3 in the region is owing to high consumer awareness regarding the benefits of omega 3, and growing health concerns. Asia-Pacific is expected to grow at the highest CAGR during the forecast period owing to increasing disposable incomes in developing countries of this region, and rising demand of omega 3 for infant formula, animal feed, and pharmaceutical.


The different applications of omega 3 include functional food and supplements, pharmaceutical, infant formula, animal feed, and others. In 2017, functional food and supplements segment accounted for the highest market share. Use of omega 3 in functional food and supplements provide proper nutrition and enable efficient functioning of human bodies. The increasing demand of functional food and supplements from athletes and sports sector further supports market growth.

The well-known companies profiled in the report include Omega Protein Corporation, Croda International PLC, Arista Industries Inc., Cargill, Inc., Royal DSM, Pharma Marine AS, GC Reiber Oils, Nordic Naturals Inc., Reckitt Benckiser Group plc, Pharma Nord B.V., Pharmavite LL, and Natrol LLC among others. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

on No comments:
Labels: , , ,

Artificial Intelligence Market Growth, Challenges, Opportunities and Emerging Trends 2019-2026

According to a new study published by Polaris Market Research the global artificial intelligence market is anticipated to reach USD 54 billion by 2026. The advancements of robots and the rise in their deployment rate particularly, in the developing economies globally have had a positive impact on the global artificial intelligence market. Augmented customer experience, expanded application areas, enhanced productivity, and big data integration has highly propelled artificial intelligence market worldwide. Although, absence of adequate skilled workforce as well as threat to human dignity are some of the factors that could affect the growth of the market. However, these factors are expected to have minimal impact on the market attributed to the introduction of advanced technologies.

An extraordinary increase in productivity has been achieved with machine-learning. For instance, Google, with the help of its experimental driverless technology has transformed cars including, Toyota Prius. Integration of various tools by artificial intelligence has helped in the transformation of business management. These tools include brand purchase advertising, workflow management tools, trend predictions among others. For example, the Google’s voice accuracy technology has 98% of accuracy rate. Furthermore, Facebook’s DeepFace technology has a success rate of approximately 97% in recognizing faces. Such accuracy in technologies is further anticipated to bolster the market growth during the forecast period.


Currently, North America dominates the global artificial intelligence market attributed to the high government funding availability, existence of prominent artificial intelligence providers in the region, and robust technical adoption base. Also, the region is expected to continue its dominance during the forecast period. Moreover, the adoption of cloud-based services in key economies, such as the US and Canada, is considerably adding to the market growth in the North American region. The markets in Asia Pacific, MEA and South America region are expected to notice a high growth during the coming years. The growth in Asia Pacific region is attributed to the increasing demand for artificial technologies by the developing economies. Thus, the region is anticipated to grow at the highest CAGR during the forecast period.

Major companies profiled in the report include Google Inc., Intel Corporation, Nvidia Corporation, Microsoft Corporation, IBM Corporation, General Vision, Inc., Qlik Technologies Inc., MicroStrategy, Inc., Brighterion, Inc., and Baidu, Inc. among others.

  
Key Findings from the study suggest North America is expected to command the market over the forecast years. APAC is presumed to be the fastest growing market, developing at a CAGR of more than 65% over the forecast period. The artificial intelligence market is presumed to develop at a CAGR of over 55.9% from 2018 to 2026. The high implementation of artificial intelligence in several end-user verticals including, retail, automotive and healthcare is projected to boost the growth of the market over the forecast period. Several companies are making considerable investments to integrate artificial intelligence competences into their portfolio of products. For instance, in 2016, SK Telecom and Intel Corporation signed an agreement for the development of the artificial intelligence based vehicle-to-everything (V2X) technology as well as video recognition.
on No comments:
Labels: , , ,

Viscosupplementation Market Report 2020 Competitive Landscape, Trends and Opportunities

The global viscosupplementation market is estimated to reach USD 6.9 billion by 2026 growing at a CAGR of 8.9% during the forecast period, according to a new study published by Polaris Market Research. The report ‘Viscosupplementation Market Share, Size, Trends & Industry Analysis Report By Product Type (Single injection, Three injection, Five injection); By Application (Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis); By Regions, Segment Forecast, 2020 – 2026’ provides an extensive analysis of present market dynamics and predicted future trends.

Due to growing geriatric population globally and due to increasing occurrences of osteo arthritis, injuries, gingivitis, & abscess, this market is anticipated to gain traction. According to assessment done by WHO, the population of people who are of the age of 65 g and above globally would increase significantly from 7% in the year 2000 and is estimated to grow to 16% by 2050. This significant growth in the elderly population would result in the increased problems of obesity and osteo arthritis, which would indirectly help this market to gain traction during the forecast period.  Together with expanding choice for minimally intrusive surgical procedures, worldwide rise in the target populace is anticipated to substantially push the need for viscosupplements throughout the forecast duration.


Geographically, North America is estimated to be the largest viscosupplementation market in 2019.  According to Centers for Condition Control as well as Avoidance (CDC) in 2015, over 30 million individuals in the United States experienced osteo arthritis and also around 10% individuals over 55 years endured knee discomfort. These growing numbers are pushing the market growth in this region. Asia Pacific on the other hand is anticipated to be the fastest growing market in 2017 and is estimated to preserve its placement throughout the projection period. This growth rate can be made up by the visibility of a considerable growing base of senior citizens, which is vulnerable to problems such as osteo arthritis as well as rheumatoid joint inflammation. Increasing demand for minimally intrusive treatments is a considerable element adding to the growth rate of Asia Pacific. The Latin American market is anticipated to expand at a rewarding pace in the coming years because of the visibility of high unmet clinical requirements, increasing disposable income and growing awareness among the patients in economies such Brazil and Mexico.

Among the viscosupplementation products, three injection products are estimated to be the largest segment of the viscosupplementation market. Affordability and shorter therapy duration are some the major factors which are pushing the growth of this product segment. This is closely followed by the single injection.  


Major companies operating in the market are focusing on incorporating modern technologies to make innovative viscosupplements. For instance, Anika Therapeutics introduced HYAFF, which aids in production of very efficient biocompatible viscosupplements. The FDA authorized hyaluronates presently offered in the viscosupplementation market are Hyalgan (Sanofi), Euflexxa (Ferring Pharmaceuticals, Inc.), Orthovisc (Anika Rehabs), Supartz, Gel-One (Seikagaku Company), Synvisc, Synvisc One (Genzyme) and also Durolane (Q MEDICATION ABDOMINAL). Some of the major players in this market include Seikagaku Corporation, Lifecore Biomedical, LLC, Zimmer Holdings Inc, Bioventus, Ferring B.V., Sanofi, Anika Therapeutics, Inc., and LG Life Sciences Ltd.

on No comments:
Labels: , ,
Subscribe to: Comments (Atom)